FDA'S policy statement for the development of new stereoisomeric drugs
- 1 January 1992
- Vol. 4 (5) , 338-340
- https://doi.org/10.1002/chir.530040513
Abstract
No abstract availableThis publication has 0 references indexed in Scilit:
This publication has 0 references indexed in Scilit: